John A Auchampach Selected Research

John A Auchampach Research Topics

Disease

11	Reperfusion Injury 01/2019 - 03/2003
9	Ischemia 01/2023 - 07/2002
8	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 03/2003
8	Myocardial Infarction 01/2023 - 08/2002
8	Infarction (Infarctions) 01/2012 - 08/2003
7	Inflammation (Inflammations) 01/2023 - 05/2006
4	Neuralgia (Stump Neuralgia) 08/2022 - 07/2013
4	Coronary Occlusion 08/2010 - 03/2003
3	Neoplasms (Cancer) 01/2023 - 05/2013
3	Hypothermia 01/2022 - 01/2017
2	Hypertension (High Blood Pressure) 12/2015 - 07/2014
1	Fibrosis (Cirrhosis) 12/2020
1	Body Weight (Weight, Body) 12/2015
1	Chronic Disease (Chronic Diseases) 12/2015
1	Pain (Aches) 12/2014
1	Cardiomegaly (Heart Hypertrophy) 07/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2013
1	Peritonitis 08/2010
1	Hypoxia (Hypoxemia) 12/2009
1	Heart Block 06/2004
1	Cardiomyopathies (Cardiomyopathy) 06/2004
1	Heart Failure 03/2004
1	Ventricular Fibrillation 03/2003
1	Unstable Angina 08/2002

Drug/Important Bio-Agent (IBA)

18	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2023 - 07/2002
10	Adenosine (Adenocard)FDA LinkGeneric 01/2018 - 05/2006
3	NucleosidesIBA 01/2022 - 10/2011
3	CP-532,903IBA 01/2019 - 01/2008
3	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 08/2010 - 08/2003
3	triphenyltetrazoliumIBA 03/2004 - 03/2003
2	AcetyltransferasesIBA 01/2023 - 01/2022
2	BAY 60-6583IBA 01/2018 - 11/2010
2	ThromboxanesIBA 07/2014 - 03/2003
2	Barbital (Barbitone)IBA 01/2012 - 03/2004
2	Adenosine Triphosphate (ATP)IBA 01/2008 - 08/2003
2	Phosphotransferases (Kinase)IBA 01/2007 - 08/2002
1	Histones (Histone)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	GuaiacolIBA 01/2022
1	Tamoxifen FDA LinkGeneric 12/2020
1	Cre recombinaseIBA 12/2020
1	PSB-0777IBA 01/2018
1	N(6)-cyclopentyladenosineIBA 01/2017
1	N(6)-cyclohexyladenosineIBA 01/2017
1	Adenosine Monophosphate (AMP)IBA 01/2017
1	LipopolysaccharidesIBA 12/2015
1	Glucose (Dextrose)FDA LinkGeneric 12/2015
1	CytokinesIBA 12/2015
1	MRS5698IBA 12/2014
1	Purinergic P1 Receptor AgonistsIBA 12/2014
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 07/2014
1	Angiotensin IIIBA 07/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2014
1	Losartan (Cozaar)FDA LinkGeneric 07/2014
1	Myosin-Light-Chain PhosphataseIBA 07/2014
1	Angiotensin II Type 1 Receptor BlockersIBA 07/2014
1	PAMAM StarburstIBA 10/2011
1	Chloride Channels (Chloride Channel)IBA 06/2011
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 06/2011
1	Troponin IIBA 11/2010
1	Superoxides (Superoxide)IBA 06/2010
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2010
1	Isoflurane FDA LinkGeneric 01/2010
1	arginine methyl esterIBA 01/2010
1	CannabidiolIBA 12/2008
1	Retinaldehyde (Retinal)IBA 12/2008
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 12/2008
1	PotassiumIBA 01/2008
1	KATP ChannelsIBA 01/2008
1	Opioid Receptors (Opioid Receptor)IBA 01/2007
1	LigandsIBA 01/2007
1	2,3- diethyl- 4,5- dipropyl- 6- phenylpyridine- 3- thiocarboxylate- 5- carboxylateIBA 12/2006
1	ZM 241385 (ZM241385)IBA 12/2006
1	Phenol (Carbolic Acid)FDA Link 12/2006
1	pyridineIBA 12/2006
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 05/2006
1	1,3- dipropyl- 8- (2- (5,6- epoxy)norbornyl)xanthineIBA 03/2004
1	BG 9928IBA 03/2004
1	XanthineIBA 03/2004
1	PropionatesIBA 03/2004
1	DiureticsIBA 03/2004
1	Purinergic P1 Receptor AntagonistsIBA 03/2004
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 08/2003
1	Potassium Channels (Potassium Channel)IBA 08/2003
1	Saline SolutionIBA 08/2003
1	Glyburide (Glibenclamide)FDA LinkGeneric 08/2003
1	6- isopropyl- 3- (4- (4- chlorobenzenesulfonylamino)butyl)azulene- 1- sulfonic acid sodium saltIBA 03/2003
1	daltrobanIBA 03/2003

Therapy/Procedure

1	Microspheres (Microsphere) 08/2003